« Return to News | Drug Sponsors

Actavis to expand Florida manufacturing facility, create 220 jobs

Wednesday, March 27, 2013 10:55 AM

Actavis, a specialty pharmaceutical company formerly known as Watson Pharmaceuticals, plans to expand its pharmaceutical manufacturing and warehousing facilities in Davie, Fla., resulting in the creation of 220 jobs.

The expansion will involve the construction of a 30,000 square foot addition comprising approximately 16,700 square feet of pharmaceutical manufacturing space and 13,000 square feet of warehouse space. To increase production, Actavis will invest about $40.5 million at the Davie site, which will include the construction of the additional space, as well as investment within its existing facility. Construction is slated to begin in the third quarter of 2013, with completion anticipated in one year and initiation of operations to follow.

Actavis has been approved for nearly $2.9 million in grants, tax refunds and employee training incentives (state and local) to support its expansion. Organizations that assisted the company in facilitating its expansion were Enterprise Florida, Greater Fort Lauderdale Alliance, State of Florida and the Town of Davie.

The Actavis Davie manufacturing facility, in operation since 1992, comprises manufacturing, warehouse, quality, engineering and shared services. The site manufactures about 2.2 billion units annually and is approved by the FDA, Health Canada, and the EMA.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.